Steglujan

Active Ingredient(s): Ertugliflozin + Sitagliptin Phosphate
FDA Approved: * December 19, 2017
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Steglujan Overview

Sitagliptin, sold under the brand name Januvia among others, is an medication used to treat diabetes mellitus type 2.[2] It is generally less preferred than metformin or a sulfonylurea.[3] It is taken by mouth.[2] It is also available within a single pill as metformin/sitagliptin.[2] Common side effects include headaches, swelling of the legs, and upper respiratory tract infections.[2] Serious side effects may inc...

Read more Steglujan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sitagliptin

Recent Steglujan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ertugliflozin + Sitagliptin Phosphate
  • Tablet: 15mg + 100mg, 5mg + 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Steglujan: (2 results)

Sorted by National Drug Code
  • 0006-5367 Steglujan Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5368 Steglujan Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Drugs with one or more similar ingredients: (9 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA